Kalpa Pharmaceuticals has been earning considerable notice recently, thanks to a series of successful breakthroughs and a significant growth in its offerings. While still a newer company, Kalpa’s focus on niche therapies, particularly in oncology rare diseases , has set it as a possible contender in the challenging pharmaceutical sphere. Analysts